Viewing Study NCT00176566


Ignite Creation Date: 2025-12-24 @ 4:11 PM
Ignite Modification Date: 2025-12-28 @ 7:33 AM
Study NCT ID: NCT00176566
Status: TERMINATED
Last Update Posted: 2009-12-11
First Post: 2005-09-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia
Sponsor: University of Medicine and Dentistry of New Jersey
Organization:

Study Overview

Official Title: A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia
Status: TERMINATED
Status Verified Date: 2009-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Transitioned into a national study through ECOG
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: You have been asked to participate in this research study because you have or may have oral leukoplakia. Oral leukoplakia is described as a white patch or plaque on the oral mucosa (mouth) that will not rub off and cannot be removed by scraping, reversed by elimination of obvious irritants (things that cause redness and/or swelling) such as dentures (artificial replacment for missing teeth), or lesions as described that are diagnosed by your dentist.
Detailed Description: Since oral leukoplakia may precede the development of cancer, using agents that may prevent cancer, called chemoprevention, may be useful. The purpose of this study is to determine whether taking a green tea preparation may have effects on your leukoplakia. It is hoped that these effects may reduce the subsequent risk of cancer in or around the area of leukoplakia. To assess for these effects, samples of the lining of your mouth will be obtained, and they will be analyzed looking for certain features (biomarkers).

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
CINJ#120301 None None View